Literature DB >> 28264642

Editorial: Targets for Immunotherapy in Acute Leukemia.

Christopher S Hourigan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28264642      PMCID: PMC6354584          DOI: 10.2174/1389450117999151116144835

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


× No keyword cloud information.
  1 in total

1.  SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints.

Authors:  Yunzhu Dong; Xinghui Zhao; Xiaomin Feng; Yile Zhou; Xiaomei Yan; Ya Zhang; Jiachen Bu; Di Zhan; Yoshihiro Hayashi; Yue Zhang; Zefeng Xu; Rui Huang; Jieyu Wang; Taoran Zhao; Zhijian Xiao; Zhenyu Ju; Paul R Andreassen; Qian-Fei Wang; Wei Chen; Gang Huang
Journal:  Leukemia       Date:  2019-04-09       Impact factor: 11.528

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.